开发四种与自相关的基因特征,用于积极结核病诊断
Baoyan Ren1, Feng Jia2, Qixun Fang1
1Yaneng Bioscience Co. Ltd., Shenzhen, Guangdong, China.
Frontiers in cellular and infection microbiology
|June 9, 2025
概括
一种新的四基因血液测试通过分析与自相关的基因来准确检测活性结核病 (TB). 这种具有成本效益的生物标志物签名有助于诊断结核病,使其与潜在感染和其他疾病区分开来.
科学领域:
- 生物标志物和诊断方法
- 分子生物学分子生物学
- 传染性疾病 传染性疾病
背景情况:
- 传统的结核病 (TB) 诊断在区分活动性结核病 (ATB) 和潜伏性感染 (LTBI),健康对照 (HCs) 和其他疾病 (ODs) 方面存在局限性.
- 迫切需要非唾液生物标志物来改善结核病诊断.
研究的目的:
- 识别和验证一种新的,非唾液生物标志物签名,用于准确诊断活跃结核病.
- 制定一个具有成本效益的,基于血液的诊断策略,与世卫组织的目标保持一致.
主要方法:
- 分析了来自两个数据集 (GSE83456,GSE152532) 的转录组数据,以确定与自相关的基因的差异表达.
- 随机森林分类器识别了标记基因,线性支持矢量机 (SVM) 选择了最佳的四基因签名.
- 通过RT-qPCR和SVM分析,通过六个独立数据集和70名参与者的全血样本验证了该签名.
主要成果:
- 与四个基因自相关的特征 (CASP1,FAS,TRIM5,C5) 被识别出,具有很高的诊断准确性.
- 该签名在多个数据集中显示出强大的性能:AUC 0.83-0.98 (ATB与LTBI) 和0.82-0.94 (ATB与HC).
- 对其他疾病观察到高特异性 (AUC 0.89-0.90),全血验证显示有希望的差异化 (SVM AUC 0.86-0.99).
结论:
- 一个经过验证的基于血液的四基因签名可以准确地诊断出活跃的结核病.
- 自驱动的,PCR兼容的签名提供了一种具有成本效益的方法来增强结核病检测.
- 这一血液生物标志物战略解决了结核病诊断的关键需求,与全球卫生目标保持一致.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
7.8K
相关概念视频
01:26Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
01:31Pulmonary Tuberculosis III
312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
312
01:28Pulmonary Tuberculosis II
213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170